Maronese CA, Valenti M, Moltrasio C, et al. Paradoxical
psoriasis: an updated review of clinical features, pathogenesis,
and treatment options....
Navarro R, Daudén E. Clinical Management of paradoxical
psoriasiform reactions during TNF- α therapy. Actas
Dermosifiliogr. 2014;105:752–761.
Aeberli D, Seitz M, Jüni P, et al. Increase of peripheral CXCR3
positive T Lymphocytes upon treatment of RA patients with
TNF-alpha inhibitors....
Munera-Campos M, Ballesca F, Carrascosa JM. Paradoxical
reactions to biologic therapy in psoriasis: a review of the
literature. Actas Dermosifiliogr...
Chaitidis N, Papadopoulou Z, Varvara ST, Panagiotidis M,
Katsigianni I, Sakellariou GT. Paradoxical psoriasis induced by
IL-17 inhibitors:...
Martora F, Battista T, Potestio L, et al. Severe paradoxical scalp
psoriasis induced by Bimekizumab in a young multifailure
hidradenitis suppurativa...
Tan TL, Taglia L, Yazdan P. Drug-induced psoriasiform alopecia
associated with interleukin-17 inhibitor therapy. J Cutan Pathol.
2021;48:771–774.
Mylonas A, Conrad C. Psoriasis: classical vs paradoxical. The
Yin-Yang of TNF and type I interferon. Front Immunol. 2018;9:2746.
Hu JZ, Billings SD, Yan D, et al. Histologic comparison of tumor
necrosis factor-α inhibitor-induced psoriasis and psoriasis
vulgaris. J Am...
